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Limulus amebocyte lysateLiposomes containing cholesterol (Chol) have long been used as an important membrane system for modeling
the complex interactions of Chol with adjacent phospholipids or other lipids in a membrane environment. In
this study we utilize a probe composed of QS-21, a saponin molecule that recognizes liposomal Chol and causes
hemolysis of erythrocytes. The interaction of QS-21 with liposomal Chol results in a stable formulation which,
after injection into the tissues of an animal, lacks toxic effects of QS-21 on neighboring cells that contain Chol,
such as erythrocytes. Here we have used liposomes containing different saturated phospholipid fatty acyl groups
and Chol, with or without monophosphoryl lipid A (MPLA), as model membranes. QS-21 is then employed as a
probe to study the interactions of liposomal lipids on the visibility of membrane Chol. We demonstrate that
changes either in the mole fraction of Chol in liposomes, or with different chain lengths of phospholipid fatty
acyl groups, can have a substantial impact on the detection of Chol by the QS-21.We further show that liposomal
MPLA can partially inhibit detection of the liposomal Chol by QS-21. The Limulus amebocyte lysate assay is used
for binding to and detection of MPLA. Previous work has demonstrated that sequestration of MPLA into the
liposomal lipid bilayer can block detection by the Limulus assay, but the binding site on the MPLA to which the
Limulus protein binds is unknown. Changes in liposomal Chol concentration and phospholipid fatty acyl chain
length inﬂuenced the detection of the liposome-embedded MPLA.
Published by Elsevier B.V.1. Introduction
Molecular heterogeneity of mixtures of phospholipids, cholesterol
(Chol), and other lipids in liposomal model membranes can lead to
complex spatial patterns, different thermotropic phase distributions,
lipid polymorphisms, and structural changes of different classes, types,
and groups of individual species of the membrane lipids [1–6]. It is
believed that the liposomal lipid bilayer can exist simultaneously and
dynamically in a “liquid-disordered (ﬂuid)” and “liquid ordered”
phase in which the coexisting liquid phases differ in the different de-
grees of acyl chain order [7,8]. An intermediate phase has been further
postulated that is ordered in the conformational structure of the lipid
chains but is disordered based on the lateral positions of the molecules
[7,8]. Intermediate phases ofmembrane lipidsmay bemanifested in the
formof lipid “rafts” that can bemicroscopic or evennanoscopic domains
[9,10].Antigen Research, U.S. Military
f Research, 503 Robert Grant
449; fax: +1 301 319 7518.In the elucidation of membrane organization, Chol has played a key
role and exhibits great versatility from a functional standpoint because
of the many types of chemical and physical interactions both with
other membrane lipids [11–13], and even with membrane-associated
proteins [14,15]. The complexities of self-association of Chol molecules,
with resultant superlattice and other types of geometric formations
[16–18], result in liposomal surface areas or patches that can be probed
at the membrane–water interface with a variety of water-soluble
chemicals, such as cholesterol oxidase [6,19], cytolytic toxins [20,21],
or even monoclonal antibodies [22].
In the present study, in order to model the surface characteristics of
complex lipid bilayers we utilized variations of lipids related to those of
a unique liposomal formulation known as AS01, a liposomal membrane
system that serves as an adjuvant constituent in commercial vaccines to
malaria and other diseases [23]. As originally described in a 1996 patent
application publication [24], and also taught in subsequent disclosures
[25,26], a preferred form of AS01 comprises liposomes containing
dioleoyl phosphatidylcholine (DOPC), Chol and monophosphoryl lipid
A (MPLA) (the lipid moiety of Gram-negative bacterial lipopolysaccha-
ride) [27], together with QS-21, a member of the saponin family.
QS-21 is extracted from the bark of Quillaja saponaria tree in Chile
[28], and consists of two hydrophilic head groups with several sugar
residues, and a hydrophobic region comprised of a triterpene group
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bind to Chol in lipid bilayers of erythrocytes or liposomes, resulting in
irreversible pore formation that is associated with hemolysis of
erythrocytes and permeability of liposomes [30,31]. Binding of QS-21
to liposomal Chol results in reduced toxicity to neighboring erythro-
cytes, but this detoxiﬁcation process still allows retention of adjuvant
activity [24–26]. Here we utilized QS-21 as a probe to examine the
roles of liposomal phospholipids and other lipids, and the effects of
varying mole fractions of liposomal Chol, on the surface accessibility
of liposomal Chol.
AS01 liposomes are prepared by hydration of a dried lipid ﬁlm
[24–26], and this is thus a preparation that theoretically might con-
tain some demixed free cholesterol [32]. In addition, the physical
structure of the liposomes may be dramatically altered by the in-
teraction of QS-21 with membrane Chol [33]. Thus, AS01 is an in-
teresting, complex, and stable suspension of liposomal lipids in
which the manufacture is sufﬁciently reproducible to have been
employed as an adjuvant structure in numerous government-
regulated experimental vaccines [23].
Lipid A is a set of acylated and amidated diglucosamine diphosphate
molecular congeners, andMPLA represents oneormore congeners lack-
ing the glucosamine C1 phosphate [27,34]. In this study we used the
Limulus amebocyte lysate (LAL) assay as a probe to examine the roles
of phospholipid chain length andmole fraction of Chol on the liposomal
surface expression of MPLA. A lysate of amebocytes from the blood of
Limulus polyphemus (Atlantic horseshoe crab) containing a clotting
protein is widely used as a surrogate probe for detecting the endotoxic
activity of LPS or lipid A [35]. Although the exact molecular epitope or
structure of lipid A (or MPLA) to which the Limulus protein binds is
still not completely clear, incorporation of lipid A into the liposomal
bilayer greatly masks both the endotoxic and the LAL activities
[36–38]. It is believed that masking of the LAL activity is due to seques-
tration of the “Limulus-reactive” group of lipid A in the liposomal lipid
bilayer resulting in inhibition of binding of the Limulus protein to
the lipid A. However, “Limulus-positive” (i.e., reactive) and “Limu-
lus-negative” (non-reactive) liposomes can be created by varying
the concentration of liposomal lipid A to higher or lower amounts,
respectively [39]. As with other liposomal lipids, lipid A can self-
associate to form lipid A-enriched domains [40], and these may be
lamellar or non-lamellar [41]. High concentrations of liposomal
lipid A presumably lead to self-association or phase separation,
with increased surface visibility of the Limulus-reactive group of
lipid A.
In the work described here we have found that changes of the mole
fractions of liposomal Chol in liposomes having different phospholipid
compositions can have substantial impacts on the detection of Chol by
the QS-21. Similarly the changes in liposomal Chol concentration can
inﬂuence the detection of the liposomal MPLA by the Limulus assay.
Likewise, the presence of liposomal MPLA itself can also inﬂuence the
detection of the liposomal Chol by the QS-21.2. Materials and methods
2.1. Lipids and saponins
Dimyristoyl phosphatidylcholine (DMPC), dipalmitoyl phosphati-
dylcholine (DPPC), distearoyl phosphocholine (DSPC), dimyristoyl
phosphatidylglycerol (DMPG), cholesterol (Chol), and synthetic
monophosphoryl lipid A (MPLA) (PHAD™) were purchased from
Avanti Polar Lipids (Alabaster, AL, USA). DMPC, DPPC, DSPC, and Chol
were dissolved in chloroform and DMPG was dissolved in
chloroform:methanol (9:1). Each lipid stock solution was prepared
fresh using distilled chloroform. PuriﬁedQS-21was purchased fromDe-
sert King International (San Diego, CA, USA). Saponin stock solutions (1
mg/ml) were made in PBS (pH 7.0).2.2. Preparation of liposomes
Liposomes were prepared as previously described [42]. Lipids
were mixed, dried under vacuum, and then liposomes were formed
in PBS, pH:7.4, in a ﬁnal concentration of either 50 mM or
1.272 mM of total phospholipids, as noted. Liposomal phosphatidyl-
choline and phosphatidylglycerol were in a molar ratio of 9:1. Lipo-
somal Chol varied as indicated. When MPLA was used the molar
ratio of total phospholipid:MPLA was 45:1, or 5.6:1 where indicated.
The mole percent concentrations of liposomal Chol indicated in
each ﬁgure are based on the ratio of Chol:total phospholipid
(i.e., phosphatidylcholine and phosphatidylglycerol) originally
used in the preparation of the liposomes.2.3. Cholesterol analysis
Cholesterol analysis was routinely used to conﬁrm the cholesterol
content in the liposome preparation [43]. One to 100 μl of liposomes
was diluted in water in a ﬁnal volume of 100 μl and then was added
to 3ml of glacial acetic acid. Twomilliliters of 0.1% ferric chloride/glacial
sulfuric acid was slowly layered on the samples. After mixing and then
equilibrating the samples to room temperature, the absorbance was
read at 560 nm. Standard cholesterol concentration curvewith linear re-
gression was used to determine the cholesterol concentration in each
preparation of liposomes.2.4. Hemolytic assay
Hemolysis of red blood cells was used as a measure both of the rela-
tive amount of freeQS-21, and of the toxicity of QS-21under the indicat-
ed experimental conditions. Human red blood cells were purchased
from the Research Blood Components LLC (Boston, MA, USA) under a
Walter Reed Army Institute of Research protocol reviewed by the inde-
pendent Institutional Review Board, Division of Human Subjects. Eryth-
rocytes were washed with PBS and were quantiﬁed by a Beckman
Coulter counter model ACT10 (Indianapolis IN, USA). In each assay of
this study, hemolytic activity of QS-21 incubated with or without lipo-
somes was determined in 220 μl volume and each step of the assay
was performed at room temperature (22 °C). One hundred microliters
of QS-21 dilution was incubated with 100 μl of liposomes, or PBS only,
on a Daigger Rocker (Vernon Hills, IL, USA) for 15minutes. After mixing
the liposomes, 2 × 107 erythrocytes in 20 μl of PBS were added to the
mixture and incubated on a Daigger Rocker for an additional 30 mi-
nutes. Plates were centrifuged at 800 ×g for 6 min. Supernatant was
transferred to a polystyrene 96-well plate, and absorbance was read at
541 nm. Hemolysis by QS-21 binding to liposomal Chol was expressed
as % of maximum hemolysis by free QS-21.
All of the experiments were highly reproducible. In each ﬁgure, all of
the data are shown as the mean of at least two independent experi-
ments. The curves are closely representative of the conclusions drawn
with each of the independent experiments. To illustrate this, the QS-
21 dose curves shown in Fig. 2were repeated in numerous independent
experiments, each with a separately manufactured liposome (L) or
L(MPLA) preparation containing 50 mol% Chol.2.5. Limulus amebocyte lysate assay
Limulus amebocyte lysate (LAL) Kinetic-QCL assay was purchased
from Lonza (Allendale, NJ, USA). The assay was performed on the
Spectramax M5 (Molecular Devices) platform using the SoftMax Pro
Chromo-LAL protocol at 37 °C, using the following parameters: Δt =
150 seconds, measurement ﬁlter = 405 nm, ΔOD = 0.2, number of
reads = 40. The results were presented in EU/ml units.
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3.1. Effect of liposomal Chol on hemolytic activity of co-incubated QS-21
The degree of erythrocyte damage caused byQS-21was inversely re-
lated to the mol% of liposomal Chol that had been pre-incubated with
QS-21 (Fig. 1). Free QS-21 causedmaximumhemolysis at approximate-
ly 2 μg, but when QS-21 was pre-incubated with liposomes containing
either 33.7 or 43 mol% Chol maximum hemolysis occurred at approxi-
mately 4 μg of QS-21. Liposomes having 55 mol% Chol completely
blocked the hemolytic effect of QS-21 up to 200 μg (Fig. 1).Fig. 2. Inhibition of binding of QS-21 to liposomal Chol by liposomalMPLA. QS-21was pre-
incubated with liposomes consisting of a total of 0.127 μmol of phospholipid (DMPC/
DMPG, 9/1), 50 mol% Chol, and either lacking or containing MPLA, (L) or L(MPLA)
(MPLA:phospholipid = 1:5.6), as indicated. The mean ± S.D. is shown with 14 indepen-
dent liposome batches of L, and with 4 independent batches of L(MPLA).3.2. Inhibition of binding of QS-21 to liposomal Chol by liposomal MPLA
Binding of QS-21 to DMPC/DMPG/Chol liposomes containing
0.127 μmol total phospholipids and 50 mol% Chol was compared to
the same liposomes that also contained 0.025 μmol of MPLA (DMPC/
DMPG/Chol/MPLA). As shown in Fig. 2, 50mol% Chol liposomeswithout
MPLA (L) reached 100% hemolysis only at the concentration of 25 μg of
QS-21. With liposomes having MPLA [L(MPLA)], hemolysis reached a
maximum level at 5 μg of QS-21, which was similar to the hemolytic
curve of free QS-21. It is thus clear that 50% Chol was less visible to
QS-21 in liposomes containing MPLA when compared to those lacking
MPLA.3.3. Fatty acyl chain length of the liposomal saturated phospholipids chang-
es the accessibility of liposomal Chol for binding of QS-21
Three liposome compositions containing 0.114 μmol of phosphati-
dylcholine, consisting of DMPC, DPPC, and DSPC, respectively, together
with 0.0127 μmol of DMPG, and containing either 33.7% or 55% Chol
with or without 2.85 nmol MPLA, were pre-incubated with QS-21
(Fig. 3). As shown in Fig. 3A, with up to 10 μg of QS-21, little or none
of the QS-21 bound to DMPC, DPPC, or DSPC liposomes having
33.7 mol% Chol. However, increasing the liposomal Chol to 55%
(Fig. 3B) increased the binding of QS-21 to Chol in DSPC liposomes,
and especially in DMPC liposomes. In contrast, DPPC liposomes with
55% Chol bound much less QS-21 than the DMPC or DSPC liposomes
(Fig. 3B). The presence of MPLA inhibited the binding of QS-21 to
DMPC liposomeswith 55% Chol, but did not inhibit the binding to either
DPPC or DSPC liposomes (Fig. 3C).Fig. 1. Hemolysis of erythrocytes by QS-21 pre-incubated with liposomes. QS-21 was
mixed with DMPC/DMPG liposomes containing a total of 5 μmol of phospholipids at
22 °C. The liposomes also contained either 33.7, or 43, or 55 mol% Chol, respectively.3.4. Cholesterol transfer between liposomes
As shown in Fig. 4, Chol transfer from liposomes containing 66%
Chol to liposomes lacking Chol was detected by using QS-21 as a
probe. Preincubation of QS-21 with [L(0% Chol) + L(66% Chol)] re-
sulted in hemolytic activity of QS-21 that was intermediate between
that observed after preincubation of QS-21 separately with either
L(0% Chol) or L(66% Chol) (Fig. 4A). Preincubation of QS-21 with an
equal mixture of liposomes containingMPLA, and containing or lacking
Chol [L(0% Chol + MPLA) + L(66% Chol + MPLA)] also resulted in an
intermediate level of hemolysis due to QS-21 (Fig. 4B). However, the
curve of [L(0% Chol + MPLA) + L(66% Chol + MPLA)] shown in
Fig. 4B was shifted toward greater hemolytic activity when compared
with liposomes lacking MPLA [L(0%Chol) + L(66%Chol)] (Fig. 4A). It is
thus clear that the presence of MPLA in liposomes either inhibited the
Chol transfer between liposomes or shielded the visibility of the Chol
in the mixture of liposomes.3.5. Limulus amebocyte lysate recognition of DMPC/DMPG/Chol/MPLA
liposomes can be suppressed by increasing the amount of liposomal Chol
Fig. 5A shows that the MPLA in DMPC/DMPC/Chol/MPLA, DPPC/
DMPC/Chol/MPLA, or DSPC/DMPC/Chol/MPLA liposomes containing
33.7 mol % Chol was detected by the LAL assay. The recognition of
MPLA by LAL in liposomes containing 33.7% Chol was proportional to
the length of saturated fatty acyl chains of phosphatidylcholine, with
LAL binding in the order DSPC N DPPC N DMPC. However, at 55 mol%
Chol the ability of LAL to detect MPLA in each of the liposomes was
dramatically reduced (Fig. 5B).4. Discussion
Strong interactions of QS-21 with Chol make this an interesting re-
agent to examine as a probe of liposomal Chol and adjacent bilayer lipids.
Herewe utilized QS-21 as a unique probe for studying the accessibility of
Chol in complex liposome formulations that contained DMPC, DPPC, or
DSPC, together with DMPG, and that contained or lacked MPLA. These
lipid combinations were employed because of extensive previous work
in which combinations of these and related lipids, including other
Fig. 3. Effect of phospholipid fatty acyl chain length on accessibility of liposomal Chol for binding of QS-21. The liposomes contained DMPC, DPPC, or DSPC, as indicated. (A) Liposomeswith
33.7 mol% Chol and no MPLA. (B) Liposomes with 55 mol% Chol, and no MPLA. (C) Liposomes with 55 mol% Chol and MPLA.
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liposomal model membranes hydrated from dried lipid ﬁlms [20,33,
44–50].
The major goals of this study were to utilize QS-21 as a probe to deter-
mine the relative effects of saturated phospholipid fatty acyl chain length
and the presence of MPLA on the visibility of Chol in a geometrically com-
plex membrane. Due to its six 14-carbon fatty acids that serve as a hydro-
phobic anchor, MPLA is strongly embedded in the liposomal bilayer. LAL
served as an important measure of the relative visibility of the liposomal
MPLA. It iswell known that the ratio of Chol:phospholipid solubility in lipo-
somes is not a linear function,withmajor structural differences occurring at
1:2, 1:1, and at 2:1which is the theoretical upper limit of association. Some
release of free Chol due to de-mixing has been reported to occur during hy-
dration of liposomes fromdriedﬁlms [32]. Ameanof 51±6mol%Chol up-
take was found with different batches of Chol:DPPC liposomes containing
initial ratios of 2:1 [32]. However, as indicated in Fig. 2 variation caused
by different amounts of free Chol present in different liposome batches, if
it occurred, was relatively small when compared to the interactions of lipo-
somal Chol and MPLA that were detected by QS-21.
The complex nano-architecture of the lipid bilayer is governed by
the size, shape, and orientation of the linear display of individual neigh-
boring lipid molecules and groupings of the molecules. In the present
work we have found that the lengths of the saturated fatty acyl chain
lengths of neighboring phospholipids, and the self-association of Chol
into membrane surface patches, each played an important role in the
ability of QS-21 to bind to Chol. The physical characteristics of liposomal
Chol are determined by the three main structural elements, in which a
small polar group (3β-hydroxyl) is attached to a rigid asymmetrical ste-
roid structure, and a short hydrocarbon chain attached to the steroid
ring structure at position 17 [16]. When compared to surrounding
bulk phospholipids it is estimated that Chol has a hydrophobic length
approximately equivalent to a glycerol phospholipid having 17 carbon
saturated fatty acyl chains [51]. It was proposed that functionalFig. 4. Inhibition by MPLA of Chol transfer between DMPC/DMPG liposomes. Chol transfer w
(phospholipid:MPLA = 5.6:1).mismatches can occur between the hydrophobic length of the Cholmol-
ecule and the hydrophobic thickness of the surrounding phospholipid
bilayer, based on phospholipid fatty acyl chain length [12,51].
As evidence for a functional mismatch of hydrophobic length of Chol
and adjacent phospholipids as proposed above, when Chol-dependent
cytolytic toxins (a class of molecules known as cytolysins) are used as
probes of the lipid bilayer, the ability of the cytolysin to interact with li-
posomal Chol is governed by the self-association properties of the Chol
in the context of the phospholipid composition of the bilayer, such that
tetanolysin cytolysin reached a maximum of binding at 50% Chol [20].
Binding of the θ-toxin cytolysin of Clostridium perfringens [52], and the
perﬁngolysin O cytolysin [21], to liposomes containing Chol was in the
order DMPC b DPPC b DSPC. It was proposed that phospholipids with
N17 carbon saturated fatty acyl chains (such as DSPC) pushed Cholmol-
ecules out from under the headgroup, thus making themmore exposed
for binding to the cytolysin [21]. Interestingly, in the present study we
found that DPPC was more effective than DMPC or DSPC in shielding li-
posomal Chol from binding of QS-21 (resulting in hemolysis by QS-21)
in the order DPPC b DSPC b DMPC (see Fig. 3B). Although the reason for
this differential recognition of Chol by QS-21 is unclear, we presume
that it could indicate a close physical association of Chol with DPPC be-
cause of similarities in the hydrophobic lengths of the two compounds,
and itmight be related to increased points of contact between DPPC and
Chol in the context of the surrounding bilayer.
To add to the complexity, liposomal Chol can also transfer between
co-incubated liposomes having different mole fractions of Chol
resulting in an intermediate concentration of liposomal Chol between
the donor and recipient liposomes [53–55]. The transfer process be-
tween liposomes apparently involves an aqueous-soluble form of Chol
rather than exchange through collision of liposomes [56–59]. In the
present studywe found thatQS-21 can beuseful as a probe for detecting
transfer of Chol from liposomes containing 66% Chol to those lacking
Chol. In addition, we also found that the presence of MPLA in DMPCas detected by QS-21 binding to liposomes containing either: (A) no MPLA, or (B) MPLA
Fig. 5. Increasing amounts of liposomal Chol suppress LAL positivity of DMPC/DMPG/Chol/MPLA liposomes. (A) LAL binding to liposomes containing 33.7 mol% Chol. (B) LAL binding to
liposomes containing 55 mol% Chol.
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QS-21, but also with the transfer of Chol from 66% Chol liposomes to li-
posomes lacking Chol. It should be noted that uptake of Chol by lipo-
somes lacking Chol (Fig. 4A) theoretically could have been partly due
to pre-existing free Chol in the donor liposome preparation [32]. How-
ever, the increased interference (ca. 10-fold) by liposomal MPLA of
Chol transfer from donor to recipient liposomes (Fig. 4B vs. Fig. 4A)
was an independent function of the MPLA that was present in the
donor and recipient liposomes. Interestingly, the ability of≥50% liposo-
mal Chol to transfer between adjacent lipid bilayermembranes does not
seem to have a substantial effect on the properties of liposomes in vivo.
As evidence of this, we previously showed that after injection of DMPC
liposomes containing both lipid A and 71% Chol intomice, the liposomes
were sufﬁciently stable in vivo to induce highly speciﬁc antibodies to
Chol that could bind to lipid A-free liposomes having ≥50% Chol, but
not to those containing 43% Chol [22].
As noted in Introduction, detection of liposomal MPLA by the LAL
assay is strongly dependent on the molar concentration of MPLA in
the liposomes. Upon examining liposomes containing 33.7% Chol and
MPLA, in which the liposomes had different phospholipid fatty acyl
groups, the detection of MPLA by LAL was directly related to the phos-
pholipid fatty acyl chain length, with DMPC b DPPC b DSPC (Fig. 5A).
The MPLA that we employed is a synthetic congener of MPLA that con-
tains six acylated or amidated myristoyl fatty acids; and after inclusion
of this MPLA in liposomes the mismatch of surrounding phosphatidyl-
cholines having longer fatty acyl groups (i.e., DPPC or DSPC, compared
to DMPC) was associated with, and perhaps somehow promoted,
greater visibility of the MPLA for detection by the LAL on the surface
of the liposomes. It is not yet clear which local site on MPLA is shielded
from LAL binding by DMPC.
In this study we have focused on QS-21 and LAL as representing
novel probes of the surfaces of liposomes containing Chol and MPLA.
Saponins such as QS-21 are lipid glycans that have profound physical
effects on the liposomes after binding to Chol in that they cause complex
and stable trans-membrane holes (pores) in the liposomes [31], and in-
teractions of liposomes with Quil A, a mixture of Quillaja saponins, can
result in highly complicated lipid structures [33]. The exact geometric
structure of the holes or other structures in the liposomes caused by
QS-21-Chol interaction, and their orientationwith respect to adjacent li-
posomal MPLA, is not clear. However, it is possible that after binding of
QS-21 to liposomal Chol hydrophobic regions of the liposomes could be
exposed under some conditions to allow binding of LAL to liposomal
MPLA. It thus appears that the LAL assay represents yet another unique
probe that could be useful for examining the inﬂuence of complex or
mismatched lipid mixtures that display reactive groups on the surface
of liposomal lipid bilayer membranes.
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